Hypersensitivity pneumonitis associated with home mold exposure: A retrospective cohort analysis
PLOS One · 2025
DOI: 10.1371/journal.pone.0323093 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Traci N Adams und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. Hauptthemen laut MEDLINE: Alveolitis, Extrinsic Allergic, Fungi, Environmental Exposure, Air Pollution, Indoor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Home mold exposure is a commonly overlooked cause of hypersensitivity pneumonitis. This is in part due to the limited literature supporting the association as well as the lack of exposure characterization available in reported cases. Notably, climate change, extreme weather patterns and frequent flooding continue to create conditions that promote home mold growth. As remediation has the potential to improve outcomes, clinicians need to remain vigilant in searching for and identifying potential mold exposure in suspected HP patients. The purpose of this study is to describe a large retrospective cohort of patients with home mold associated HP.
Methods
HP patients were identified retrospectively from our single center interstitial lung disease (ILD) database between 2011–2019. Patients with a moderate, high, or definite confidence diagnosis of HP were included. The presence of residential mold exposure was confirmed by medical chart review by a pulmonologist trained in exposure assessment.
Results
Home mold exposure was identified as the culprit antigen in 54 of 231 hypersensitivity pneumonitis patients. An invasive procedure (bronchoalveolar lavage, transbronchial biopsy, and/or surgical lung biopsy) was performed to confirm the diagnosis of HP in 85.7% of the cohort. Home mold was principally caused by chronic and/or recurring water intrusion. The most common locations of mold within the home included the bathroom, bedroom, and air conditioning unit. Transplant free survival was 97.7 months, which did not differ from the 50 HP patients in our cohort with HP associated with a mold exposure outside the home or patients in our cohort with HP associated with avian antigen exposure. Of the 41 patients who removed the exposure, 5 (12.2%) had a > 10% improvement in FVC, including 4 with fibrotic HP.
Conclusion
Our study is the largest to report an association between HP and home mold exposure and is the first report from the region of north Texas. As climate change continues to disrupt weather patterns causing storms and flooding in certain areas, clinicians should remain alert to the presence of mold and its potential contribution to development of HP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
- Yale Occupational Medicine and Environmental Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.
- Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.
ORCID-Profile: Traci N Adams
Zitieren
APA
Adams, T. N., Redlich, C. A., Glazer, C. S., & Gulati, M. (2025). Hypersensitivity pneumonitis associated with home mold exposure: A retrospective cohort analysis. PLOS One. https://doi.org/10.1371/journal.pone.0323093
Vancouver
Adams TN, Redlich CA, Glazer CS, Gulati M. Hypersensitivity pneumonitis associated with home mold exposure: A retrospective cohort analysis. PLOS One. 2025. doi:10.1371/journal.pone.0323093
BibTeX
@article{Adams2025,
author = {Adams, Traci N and Redlich, Carrie A and Glazer, Craig S and Gulati, Mridu},
title = {Hypersensitivity pneumonitis associated with home mold exposure: A retrospective cohort analysis},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0323093}
}
EUVIMED